title: CDC update on gonorrhea: expand treatment to limit resistance.
authors.affiliation: Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA. dougco@email.arizona.edu
authors.forename: Doug
authors.initials: D
authors.lastname: Campos-Outcalt
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D002692:Chlamydia trachomatis / Q000187:drug effects*; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D017410:Practice Guidelines as Topic; D015995:Prevalence; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D017963:Azithromycin